| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 120928-88-3 | Allatotropin (Manducasexta) (9CI); L-Phenylalaninamide,glycyl-L-phenylalanyl-L-Lysyl-L-asparaginyl-L-valyl-L-a-glutamyl-L-Methionyl-L-Methionyl-L-Threonyl-L-alanyl-L-arginylglycyl-; Manduca sexta allatotropin; Manse-AT |  | C65H103N19O17S2 | 詳情 | 供應商 | |
| 119320-26-2 | Brain natriureticpeptide-32 (swine reduced) (9CI); Natriureticfactor-26 (pig brain reduced),N-[N2-[N-[N-[N2-(1-L-seryl-L-prolyl)-L-Lysyl]-L-Threonyl]-L-Methionyl]-L-arginyl]-; 330: PN: WO0069900 SEQID: 512 unclaimed sequence; 425: PN: US20090175821 SEQID:512 claimed protein; 45: PN: US6028055 SEQID: 45 unclaimed sequence; 4: PN:US20010027181 SEQID: 6 unclaimed sequence; 6: PN: US20060051825 SEQID: 4unclaimed sequence; L-Tyrosine,L-seryl-L-prolyl-L-Lysyl-L-Threonyl-L-Methionyl-L-arginyl-L-a-aspartyl-L-serylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-arginyl-L-arginyl-L-leucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-valyl-L-leucyl-L-arginyl-L-arginyl-; Natriuretic factor-32 (pig brain reduced) |  | C149H252N52O44S3 | 詳情 | 供應商 | |
| 155575-02-3 | L-Argininamide,5-oxo-L-prolyl-L-arginyl-L-Threonyl-L-Lysyl-N-(4-Methyl-2-oxo-2H-1-benzopyran-7-yl)-; 50: PN:WO0042071 FIGURE: 18 claimed protein |  | C37H57N13O9 | 詳情 | 供應商 | |
| 130985-18-1 | L-Lysine,N6-(carboxyMethyl)-5-hydroxy-, eryThro- (9CI); N(epsilon)-(carboxyMethyl)hydroxyLysine |  | C8H16N2O5 | 詳情 | 供應商 | |
| 1622-18-0 | L-Lysine,N6-(aminoiminoMethyl)-4-hydroxy-, (4R)-; L-Lysine,N6-(aminoiminoMethyl)-4-hydroxy-, Threo-; Lysine, N6-amidino-4-hydroxy-,L-Threo- (8CI) |  | C7H16N4O3 | 詳情 | 供應商 | |
| 150045-04-8 | Histogranin (cattle)(9CI); Histogranin(ox); 9: PN: WO2006119150 SEQID: 10 unclaimed sequence; Histogranin; L-Phenylalanine,L-Methionyl-L-asparaginyl-L-tyrosyl-L-alanyl-L-leucyl-L-Lysylglycyl-L-glutaminylglycyl-L-arginyl-L-Threonyl-L-leucyl-L-tyrosylglycyl- |  | C78H119N21O21S | 詳情 | 供應商 | |
| 119975-71-2 | Pedal peptide (ApLysiacalifornica) (9CI); L-Alanine,L-prolyl-L-leucyl-L-a-aspartyl-L-seryl-L-valyl-L-tyrosylglycyl-L-Threonyl-L-histidylglycyl-L-Methionyl-L-serylglycyl-L-phenylalanyl- |  | C68H99N17O22S | 詳情 | 供應商 | |
| 116303-65-2 | 角蝰毒素S6b | Sarafotoxin S 6b(reduced) (9CI); Endothelin1 (pig reduced), 4-L-Lysine-5-L-asparticacid-6-L-Methionine-7-L-Threonine-12-L-leucine-17-L-glutamine-19-L-valine-; 33:PN: WO2004045592 SEQID: 33 unclaimed sequence; 3: PN: WO2007149343 SEQID: 3unclaimed sequence; 606: PN: US20090175821 SEQID: 728 claimed protein; 77: PN:WO0069900 SEQID: 728 unclaimed sequence; L-Tryptophan,L-cysteinyl-L-seryl-L-cysteinyl-L-Lysyl-L-a-aspartyl-L-Methionyl-L-Threonyl-L-a-aspartyl-L-Lysyl-L-a-glutamyl-L-cysteinyl-L-leucyl-L-tyrosyl-L-phenylalanyl-L-cysteinyl-L-histidyl-L-glutaminyl-L-a-aspartyl-L-valyl-L-isoleucyl-; Sarafotoxin 6b (reduced); Sarafotoxin b (reduced); Sarafotoxin-b (Atractaspisengaddensis clone S33) |  | C110H163N27O34S5 | 詳情 | 供應商 |
| 119965-38-7 | Sarafotoxin S 6a(reduced) (9CI); Endothelin1 (pig reduced), 4-L-Lysine-5-L-asparticacid-6-L-Methionine-7-L-Threonine-12-L-leucine-13-L-asparagine-17-L-glutamine-19-L-valine-; 32: PN: WO2004045592 SEQID: 32 unclaimed sequence; 605: PN: US20090175821SEQID: 727 claimed protein; 76: PN: WO0069900 SEQID: 727 unclaimed sequence; L-Tryptophan,L-cysteinyl-L-seryl-L-cysteinyl-L-Lysyl-L-a-aspartyl-L-Methionyl-L-Threonyl-L-a-aspartyl-L-Lysyl-L-a-glutamyl-L-cysteinyl-L-leucyl-L-asparaginyl-L-phenylalanyl-L-cysteinyl-L-histidyl-L-glutaminyl-L-a-aspartyl-L-valyl-L-isoleucyl-; Sarafotoxin a (reduced); Sarafotoxin-a (Atractaspis engaddensis clone S33) |  | C105H160N28O34S5 | 詳情 | 供應商 | |
| 291524-04-4 | HIS-SER-ASP-ALA-VAL-PHE-Thr-ASP-ASN-TYR-ALA-ARG-LEU-ARG-Lys-GLN-Met-ALA-VAL-Lys-Lys-ALA-LEU-ASN-SER- | (ALA11,22,28)-VIP (HUMAN, BOVINE, PORCINE, RAT); HIS-SER-ASP-ALA-VAL-PHE-Thr-ASP-ASN-TYR-ALA-ARG-LEU-ARG-Lys-GLN-Met-ALA-VAL-Lys-Lys-ALA-LEU-ASN-SER-ILE-LEU-ALA-NH2; H-HIS-SER-ASP-ALA-VAL-PHE-Thr-ASP-ASN-TYR-ALA-ARG-LEU-ARG-Lys-GLN-Met-ALA-VAL-Lys-Lys-ALA-LEU-ASN-SER-ILE-LEU-ALA-NH2; [ALA11,22,28]VIP; (ALA11,22,28)-VIP (HUMAN, BOVINE, PORCINE, RAT); [ALA11,22,28]VIP, HUMAN, PORCINE, RAT; H-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Ala-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Ala-Leu-Asn-Ser-Ile-Leu-Ala-NH2; M.W. 3160.65 C139H231N43O39S |  | C139H231N43O39S | 詳情 | 供應商 |
| 220673-95-0 | (D-PHE11,HIS12)-SAUVAGINE (11-40) | ANTISAUVAGINE-30; D-PHE-HIS-LEU-LEU-ARG-Lys-Met-ILE-GLU-ILE-GLU-Lys-GLN-GLU-Lys-GLU-Lys-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-Thr-ILE-NH2; (D-PHE11,HIS12)-SAUVAGINE (11-40); (D-PHE11,HIS12)-SAUVAGINE (11-40) TRIFLUOROACETATE SALT; H-D-PHE-HIS-LEU-LEU-ARG-Lys-Met-ILE-GLU-ILE-GLU-Lys-GLN-GLU-Lys-GLU-Lys-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THE-ILE-OH; H-D-PHE-HIS-LEU-LEU-ARG-Lys-Met-ILE-GLU-ILE-GLU-Lys-GLN-GLU-Lys-GLU-Lys-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-Thr-ILE-NH2; ANTISAUVAGINE-30; M.W. 3650.29 C161H274N48O46S |  | C161H273N47O47S | 詳情 | 供應商 |
| 230299-95-3 | LEU-VAL-Lys-PRO-ARG-Thr-SER-ARG-Thr-GLY-PRO-GLY-ALA-TRP-GLN-GLY-GLY-ARG-ARG-Lys-PHE-ARG-ARG-GLN-ARG-; APELIN-36, MOUSE, RAT; APELIN-36 (RAT, MOUSE); LEU-VAL-Lys-PRO-ARG-Thr-SER-ARG-Thr-GLY-PRO-GLY-ALA-TRP-GLN-GLY-GLY-ARG-ARG-Lys-PHE-ARG-ARG-GLN-ARG-PRO-ARG-LEU-SER-HIS-Lys-GLY-PRO-Met-PRO-PHE; LEU-VAL-Lys-PRO-ARG-Thr-SER-ARG-Thr-GLY-PRO-GLY-ALA-TRP-GLN-GLY-GLY-ARG-ARG-Lys-PHE-ARG-ARG-GLN-ARG-PRO-ARG-LEU-SER-HIS-Lys-GLY-PRO-Met-PRO-PHE |  | C185H304N68O43S | 詳情 | 供應商 | |
| 148067-21-4 | ILE-Thr-SER-PHE-GLU-GLU-ALA-Lys-GLY-LEU-ASP-ARG-ILE-ASN-GLU-ARG-Met-PRO-PRO-ARG-ARG-ASP-ALA-Met-PRO | ITSFEEAKGLDRINERMPPRRDAMP; CN412; ITSFEEAKGLDRINERMPPRRDAMP; H-ILE-Thr-SER-PHE-GLU-GLU-ALA-Lys-GLY-LEU-ASP-ARG-ILE-ASN-GLU-ARG-Met-PRO-PRO-ARG-ARG-ASP-ALA-Met-PRO-OH; ILE-Thr-SER-PHE-GLU-GLU-ALA-Lys-GLY-LEU-ASP-ARG-ILE-ASN-GLU-ARG-Met-PRO-PRO-ARG-ARG-ASP-ALA-Met-PRO; CALCINEURIN AUTOINHIBITORY FRAGMENT; CALCINEURIN AUTOINHIBITORY PEPTIDE; H-Ile-Thr-Ser-Phe-Glu-Glu-Ala-Lys-Gly-Leu-Asp-Arg-Ile-Asn-Glu-Arg-Met-Pro-Pro-Arg-Arg-Asp-Ala-Met-Pro-OH |  | C124H205N39O39S2 | 詳情 | 供應商 |
| 9007-92-5 | 胰高血糖素氫氯化物(人) | GLUCAGON HYDROCHLORIDE(HUMAN); GLUCAGON HYDROCHLORIDE(HUMAN); glucagon[pig]; glukagonnovo; his-ser-glu(nh2)-gly-Thr-phe-Thr-ser-asp-tyr-ser-Lys-tyr-leu-asp-ser-arg-arg-a; la-glu(nh2)-asp-phe-val-glu(nh2)-trp-leu-Met-asp(nh2)-Thr; l-histidyl-l-seryl-l-glutaminylglycyl-l-Threonyl-l-phenylalanyl-l-l-Threonin; l-l-alpha-aspartyl-l-seryl-l-arginyl-l-arginyl-l-alanyl-l-glutaminyl-l-alpha-a; spartyl-l-phenylalanyl-l-valyl-l-glutaminyl-l-tryptophyl-l-leucyl-l-Methionyl- |  | C33H48N10O12 | 詳情 | 供應商 |
| 491851-53-7 | HEMOKININ 1 (HUMAN) | HEMOKININ 1 (HUMAN); H-Thr-GLY-Lys-ALA-SER-GLN-PHE-PHE-GLY-LEU-Met-NH2; HHK-1; HK-1 (HUMAN); HEK-1 (HUMAN); HEMOKININ 1 (HUMAN); Thr-GLY-Lys-ALA-SER-GLN-PHE-PHE-GLY-LEU-Met-NH2 |  | C54H84N14O14S | 詳情 | 供應商 |
| 843782-19-4 | LEU-PRO-ARG-LEU-LEU-HIS-Thr-ASP-SER-ARG-Met-ALA-Thr-ILE-ASP-PHE-PRO-Lys-Lys-ASP-PRO-Thr-Thr-SER-LEU- | H-LEU-PRO-ARG-LEU-LEU-HIS-Thr-ASP-SER-ARG-Met-ALA-Thr-ILE-ASP-PHE-PRO-Lys-Lys-ASP-PRO-Thr-Thr-SER-LE; H-LEU-PRO-ARG-LEU-LEU-HIS-Thr-ASP-SER-ARG-Met-ALA-Thr-ILE-ASP-PHE-PRO-Lys-Lys-ASP-PRO-Thr-Thr-SER-LEU-GLY-ARG-PRO-PHE-PHE-LEU-PHE-ARG-PRO-ARG-ASN-NH2; NEUROMEDIN S (RAT); NMS (RAT) | 無 | C193H307N57O49S | 詳情 | 供應商 |
| 383415-79-0 | TRP-TYR-Lys-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-Thr-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-Met-GLY-LEU | H-TRP-TYR-Lys-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-Thr-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-Met-GLY-LEU-OH; NPW-23 (HUMAN); NEUROPEPTIDE W-23 (HUMAN); TRP-TYR-Lys-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-Thr-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-Met-GLY-LEU; H-TRP-TYR-Lys-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-Thr-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-Met-GLY-LEU-OH |  | C119H183N35O28S | 詳情 | 供應商 |
| 143748-18-9 | PACAP (6-38), HUMAN, OVINE, RAT | H-PHE-Thr-ASP-SER-TYR-SER-ARG-TYR-ARG-Lys-GLN-Met-ALA-VAL-Lys-Lys-TYR-LEU-ALA-ALA-VAL-LEU-GLY-Lys-AR; FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; HIS-SER-ASP-GLY-ILE-PHE-Thr-AP-SER-TYR-SER-ARG-TYR-ARG-Lys-GLN-Met-ALA-VAL-Lys-Lys-TYR-LEU-ALA-ALA-VAL-LEU-GLY-Lys-ARG-TYR-Lys-GLN-ARG-VAL-Lys-ASN-Lys-NH2; H-PHE-Thr-ASP-SER-TYR-SER-ARG-TYR-ARG-Lys-GLN-Met-ALA-VAL-Lys-Lys-TYR-LEU-ALA-ALA-VAL-LEU-GLY-Lys-ARG-TYR-Lys-GLN-ARG-VAL-Lys-ASN-Lys-NH2; PHE-Thr-ASP-SER-TYR-SER-ARG-TYR-ARG-Lys-GLN-Met-ALA-VAL-Lys-Lys-TYR-LEU-ALA-ALA-VAL-LEU-GLY-Lys-ARG-TYR-Lys-GLN-ARG-VAL-Lys-ASN-Lys-NH2; PITUITARY ADENYLATE ACTIVATING POLYPEPTIDE (6-38) (HUMAN, OVINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (6-38), HUMAN, OVINE, RAT; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38 (6-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE (6-38) AMIDE (HUMAN, OVINE, RAT) |  | C203H331N63O65S | 詳情 | 供應商 |
| 118025-43-7 | PHM-27 (HUMAN); PHI HUMAN; PHM-27 (HUMAN); PHM, HUMAN; PEPTIDE HISTIDINE MetHIONINE, HUMAN; H-HIS-ALA-ASP-GLY-VAL-PHE-Thr-SER-ASP-PHE-SER-Lys-LEU-LEU-GLY-GLN-LEU-SER-ALA-Lys-Lys-TYR-LEU-GLU-SER-LEU-Met-NH2; HIS-ALA-ASP-GLY-VAL-PHE-Thr-SER-ASP-PHE-SER-Lys-LEU-LEU-GLY-GLN-LEU-SER-ALA-Lys-Lys-TYR-LEU-GLU-SER-LEU-Met-NH2; M.W. 2985.41 C135H214N34O40S |  | C135H214N34O40S | 詳情 | 供應商 | |
| 148439-49-0 | PRION PROTEIN (106-126) (HUMAN) | H-Lys-Thr-ASN-Met-Lys-HIS-Met-ALA-GLY-ALA-ALA-ALA-ALA-GLY-ALA-VAL-VAL-GLY-GLY-LEU-GLY-OH; H-KTNMKHMAGAAAAGAVVGGLG-OH; H-KTNMKHMAGAAAAGAWGGLG-OH; H-Lys-Thr-ASN-Met-Lys-HIS-Met-ALA-GLY-ALA-ALA-ALA-ALA-GLY-ALA-VAL-VAL-GLY-GLY-LEU-GLY-OH; KTNMKHMAGAAAAGAVVGGLG; Lys-Thr-ASN-Met-Lys-HIS-Met-ALA-GLY-ALA-ALA-ALA-ALA-GLY-ALA-VAL-VAL-GLY-GLY-LEU-GLY; PRION PROTEIN FRAGMENT 106-126 HUMAN; PRION PEPTIDE (106-126), HUMAN; PRION PROTEIN (106-126) (HUMAN) |  | C80H138N26O24S2 | 詳情 | 供應商 |